These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 20109548

  • 1. Sildenafil protects against 3-nitropropionic acid neurotoxicity through the modulation of calpain, CREB, and BDNF.
    Puerta E, Hervias I, Barros-Miñones L, Jordan J, Ricobaraza A, Cuadrado-Tejedor M, García-Osta A, Aguirre N.
    Neurobiol Dis; 2010 May; 38(2):237-45. PubMed ID: 20109548
    [Abstract] [Full Text] [Related]

  • 2. Granulocyte-colony stimulating factor attenuates striatal degeneration with activating survival pathways in 3-nitropropionic acid model of Huntington's disease.
    Lee ST, Park JE, Kim DH, Kim S, Im WS, Kang L, Jung SH, Kim MW, Chu K, Kim M.
    Brain Res; 2008 Feb 15; 1194():130-7. PubMed ID: 18166168
    [Abstract] [Full Text] [Related]

  • 3. Participation of par-4 in the degeneration of striatal neurons induced by metabolic compromise with 3-nitropropionic acid.
    Duan W, Guo Z, Mattson MP.
    Exp Neurol; 2000 Sep 15; 165(1):1-11. PubMed ID: 10964480
    [Abstract] [Full Text] [Related]

  • 4. Atorvastatin attenuates mitochondrial toxin-induced striatal degeneration, with decreasing iNOS/c-Jun levels and activating ERK/Akt pathways.
    Lee ST, Chu K, Park JE, Hong NH, Im WS, Kang L, Han Z, Jung KH, Kim MW, Kim M.
    J Neurochem; 2008 Mar 15; 104(5):1190-200. PubMed ID: 17976163
    [Abstract] [Full Text] [Related]

  • 5. Neuroprotective effect of zVAD against the neurotoxin 3-nitropropionic acid involves inhibition of calpain.
    Bizat N, Galas MC, Jacquard C, Boyer F, Hermel JM, Schiffmann SN, Hantraye P, Blum D, Brouillet E.
    Neuropharmacology; 2005 Oct 15; 49(5):695-702. PubMed ID: 15998526
    [Abstract] [Full Text] [Related]

  • 6. A novel systemically active caspase inhibitor attenuates the toxicities of MPTP, malonate, and 3NP in vivo.
    Yang L, Sugama S, Mischak RP, Kiaei M, Bizat N, Brouillet E, Joh TH, Beal MF.
    Neurobiol Dis; 2004 Nov 15; 17(2):250-9. PubMed ID: 15474362
    [Abstract] [Full Text] [Related]

  • 7. Striatal modulation of cAMP-response-element-binding protein (CREB) after excitotoxic lesions: implications with neuronal vulnerability in Huntington's disease.
    Giampà C, DeMarch Z, D'Angelo V, Morello M, Martorana A, Sancesario G, Bernardi G, Fusco FR.
    Eur J Neurosci; 2006 Jan 15; 23(1):11-20. PubMed ID: 16420411
    [Abstract] [Full Text] [Related]

  • 8. Trolox ameliorates 3-nitropropionic acid-induced neurotoxicity in rats.
    Al Mutairy A, Al Kadasah S, Elfaki I, Arshaduddin M, Malik D, Al Moutaery K, Tariq M.
    Neurotoxicol Teratol; 2010 Jan 15; 32(2):226-33. PubMed ID: 19755148
    [Abstract] [Full Text] [Related]

  • 9. 3-nitropropionic acid-induced mitochondrial permeability transition: comparative study of mitochondria from different tissues and brain regions.
    Mirandola SR, Melo DR, Saito A, Castilho RF.
    J Neurosci Res; 2010 Feb 15; 88(3):630-9. PubMed ID: 19795369
    [Abstract] [Full Text] [Related]

  • 10. Neurturin gene therapy improves motor function and prevents death of striatal neurons in a 3-nitropropionic acid rat model of Huntington's disease.
    Ramaswamy S, McBride JL, Herzog CD, Brandon E, Gasmi M, Bartus RT, Kordower JH.
    Neurobiol Dis; 2007 May 15; 26(2):375-84. PubMed ID: 17336076
    [Abstract] [Full Text] [Related]

  • 11. In vivo dopamine release and uptake impairments in rats treated with 3-nitropropionic acid.
    Kraft JC, Osterhaus GL, Ortiz AN, Garris PA, Johnson MA.
    Neuroscience; 2009 Jul 07; 161(3):940-9. PubMed ID: 19362126
    [Abstract] [Full Text] [Related]

  • 12. Phosphodiesterase 5 inhibitors prevent 3,4-methylenedioxymethamphetamine-induced 5-HT deficits in the rat.
    Puerta E, Hervias I, Goñi-Allo B, Lasheras B, Jordan J, Aguirre N.
    J Neurochem; 2009 Feb 07; 108(3):755-66. PubMed ID: 19187094
    [Abstract] [Full Text] [Related]

  • 13. Brain mitochondrial defects amplify intracellular [Ca2+] rise and neurodegeneration but not Ca2+ entry during NMDA receptor activation.
    Jacquard C, Trioulier Y, Cosker F, Escartin C, Bizat N, Hantraye P, Cancela JM, Bonvento G, Brouillet E.
    FASEB J; 2006 May 07; 20(7):1021-3. PubMed ID: 16571773
    [Abstract] [Full Text] [Related]

  • 14. IGF-1 exacerbates the neurotoxicity of the mitochondrial inhibitor 3NP in rats.
    Escartin C, Boyer F, Bemelmans AP, Hantraye P, Brouillet E.
    Neurosci Lett; 2007 Oct 02; 425(3):167-72. PubMed ID: 17868993
    [Abstract] [Full Text] [Related]

  • 15. 6-Hydroxydopamine injections into the nigrostriatal pathway attenuate striatal malonate and 3-nitropropionic acid lesions.
    Maragos WF, Jakel RJ, Pang Z, Geddes JW.
    Exp Neurol; 1998 Dec 02; 154(2):637-44. PubMed ID: 9878198
    [Abstract] [Full Text] [Related]

  • 16. Phosphodiesterase 10 inhibition reduces striatal excitotoxicity in the quinolinic acid model of Huntington's disease.
    Giampà C, Patassini S, Borreca A, Laurenti D, Marullo F, Bernardi G, Menniti FS, Fusco FR.
    Neurobiol Dis; 2009 Jun 02; 34(3):450-6. PubMed ID: 19281846
    [Abstract] [Full Text] [Related]

  • 17. Mesenchymal stem cell transplantation and DMEM administration in a 3NP rat model of Huntington's disease: morphological and behavioral outcomes.
    Rossignol J, Boyer C, Lévèque X, Fink KD, Thinard R, Blanchard F, Dunbar GL, Lescaudron L.
    Behav Brain Res; 2011 Mar 01; 217(2):369-78. PubMed ID: 21070819
    [Abstract] [Full Text] [Related]

  • 18. Endogenous dopamine enhances the neurotoxicity of 3-nitropropionic acid in the striatum through the increase of mitochondrial respiratory inhibition and free radicals production.
    Villarán RF, Tomás-Camardiel M, de Pablos RM, Santiago M, Herrera AJ, Navarro A, Machado A, Cano J.
    Neurotoxicology; 2008 Mar 01; 29(2):244-58. PubMed ID: 18093658
    [Abstract] [Full Text] [Related]

  • 19. Neuroprotective role of PDE4 and PDE5 inhibitors in 3-nitropropionic acid induced behavioral and biochemical toxicities in rats.
    Thakur T, Sharma S, Kumar K, Deshmukh R, Sharma PL.
    Eur J Pharmacol; 2013 Aug 15; 714(1-3):515-21. PubMed ID: 23831390
    [Abstract] [Full Text] [Related]

  • 20. Exacerbation of excitotoxic neuronal death induced during mitochondrial inhibition in vivo: relation to energy imbalance or ATP depletion?
    Del Río P, Montiel T, Chagoya V, Massieu L.
    Neuroscience; 2007 Jun 08; 146(4):1561-70. PubMed ID: 17490821
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.